Balasa Dinverno & Foltz LLC United Therapeutics Corp Transaction History
Balasa Dinverno & Foltz LLC
- $1.58 Billion
- Q3 2022
A detailed history of Balasa Dinverno & Foltz LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Balasa Dinverno & Foltz LLC holds 3,175 shares of UTHR stock, worth $1.14 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
3,175
Previous 3,207
1.0%
Holding current value
$1.14 Million
Previous $756,000
12.04%
% of portfolio
0.04%
Previous 0.05%
Shares
12 transactions
Others Institutions Holding UTHR
# of Institutions
619Shares Held
45MCall Options Held
368KPut Options Held
410K-
Black Rock Inc. New York, NY5.47MShares$1.96 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.42MShares$1.58 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.29MShares$1.18 Billion0.19% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$1.02 Billion12.43% of portfolio
-
State Street Corp Boston, MA2.29MShares$823 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $16.3B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...